LifeMD is a publicly traded telehealth company that predates the current wave of GLP-1-focused startups, and its weight-management program reflects that: rather than a single-purpose clinic built around one medication, LifeMD layers a weight-management track onto a broader membership that also covers primary care and urgent care. For a patient who qualifies, that program can route a prescription for brand-name Wegovy or Zepbound through the same NovoCare and LillyDirect self-pay programs used across this category, or support an insurance-covered path with prior-authorization paperwork when a plan already covers weight-management drugs.
This review covers that brand-name path specifically, and the structural questions that actually differ between LifeMD and narrower competitors: how intake and labs work, what a prior authorization involves if you are using insurance, and where the membership fee ends and the medication cost begins. It does not cover compounded semaglutide or tirzepatide, which is not FDA-approved as a finished product and is worth treating with caution if any platform, including LifeMD, defaults you toward it instead of a brand-name option you asked for. Eligibility, dosing, titration, and how to handle any side effects are decisions for your prescriber to make with you directly, not something a review like this one can substitute for.
This guide provides general information and is not medical advice. Talk to your prescriber or pharmacist before starting, stopping, or changing any medication, supplement, or device used alongside GLP-1 therapy.
What LifeMD Actually Is
LifeMD operates a national network of licensed physicians and nurse practitioners delivering care across several specialties, not just weight management, and its GLP-1 program sits inside that same account structure rather than as a standalone product. A patient signing up specifically for the weight-management track is still, technically, joining the broader LifeMD membership, which is part of why the company can support ongoing visits and lab coordination that a narrower, single-purpose platform might handle less directly.
Practically, this matters most for two kinds of readers: someone who already uses or would use LifeMD for primary care or urgent visits gets the weight-management track added at comparatively low marginal cost, while someone who only wants the GLP-1 piece is paying for infrastructure — a broader clinician network, other specialty tracks — that they may never touch. See LifeMD’s current weight-management plans to check which applies to you. Disclosure: this is an affiliate link. GLP-1 Explained may earn a commission if you buy or sign up, at no extra cost to you. This is not medical advice.
How Intake, Labs, and Ongoing Visits Work
The intake starts the way it does everywhere in this category: height, weight, and BMI checked against the FDA label threshold, plus a medical-history questionnaire covering prior weight-management attempts, current medications, and the handful of conditions — pregnancy, a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, a history of pancreatitis — that should route someone to an in-person physician instead of a prescription. A platform that skips this screening, LifeMD included, is not one to trust with a prescription.
Where LifeMD’s general-telehealth structure shows up is in the visit format: because the same account supports primary and urgent care, patients more often describe a live visit with a clinician as part of the weight-management track, rather than exclusively asynchronous messaging between check-ins. Confirm this directly during your own signup, since visit format can vary by state and clinician availability.
Labs work similarly to competitors: some patients can submit recent bloodwork, typically from within the last six to twelve months, while others are directed to a partner lab or an at-home kit. A basic metabolic panel and HbA1c are common requests, since both inform dosing decisions that belong entirely to the prescriber reviewing your case, not to you or to this review.
Brand-Name Access, Insurance, and Prior Authorization
For a self-pay patient who qualifies, LifeMD states it can prescribe brand-name Wegovy or Zepbound through the same NovoCare and LillyDirect manufacturer programs used across this category, rather than a compounded formulation. Compounded semaglutide and tirzepatide are not FDA-approved as finished products, and a platform that defaults you toward one before showing a brand-name price — at LifeMD or anywhere else — is a reason to stop and look closely rather than proceed, so confirm the brand-name path explicitly during your own intake.
For a patient using insurance, LifeMD’s prescribers can submit prior-authorization documentation when a plan already covers weight-management drugs — this is not automatic, and approval depends entirely on your specific plan’s criteria, not on LifeMD. Check eligibility and current plan options at LifeMD if you want to see how the intake handles this for your situation. Disclosure: this is an affiliate link. GLP-1 Explained may earn a commission if you buy or sign up, at no extra cost to you. This is not medical advice.
A prior-authorization decision commonly takes two to four weeks on top of the intake and lab steps, and an initial denial is not necessarily final — appeals with a stronger letter of medical necessity or a peer-to-peer review between prescriber and insurer succeed often enough to be worth pursuing before assuming the self-pay price is the only option.
Membership Cost, Medication Cost, and Who This Actually Fits
LifeMD’s weight-management membership is billed separately from the medication itself, and like every platform in this category, a specific membership dollar figure printed here would likely be out of date within a quarter — ask for the current plan pricing directly and get it in writing before your first charge. What does not change quarter to quarter is the structure: the membership fee covers clinician access and the weight-management track itself, while the self-pay price for the drug — about $499 a month for Wegovy through NovoCare, or roughly $349 to $499 a month for Zepbound through LillyDirect as of 2026 — is billed separately by the pharmacy or manufacturer program. If your insurance covers the medication instead, that per-month drug price is replaced by your plan’s copay, but the LifeMD membership fee still applies on its own, since that is the platform’s charge, not the insurer’s.
This model fits a reader who wants one telehealth relationship covering more than weight management, values a live clinician visit over pure asynchronous messaging, or is actively pursuing an insurance-covered path and wants a platform experienced with submitting prior-authorization paperwork. It fits less well for a reader who wants the single cheapest or fastest route to a brand-name prescription and has no interest in the broader membership, or who already has a primary-care doctor managing everything and does not want a second general telehealth relationship layered on top.
It is not a fit at all for anyone who is pregnant or breastfeeding, has a personal or family history of medullary thyroid carcinoma or MEN2, or has a history of pancreatitis — that combination calls for an in-person physician, and no telehealth intake, LifeMD’s included, should be treated as a substitute for that visit.
What to Look For
The combined monthly total in writing before your first charge. Membership fee plus brand-name drug cost together — not just the number that shows up first in the sign-up flow.
Confirmation that you are being routed to a brand-name prescription, not a compounded one. Ask this directly during intake rather than assuming it from marketing copy; a platform that defaults you toward a compounded product before showing a brand-name price is not the experience this review describes.
Whether your plan is being billed for prior authorization, and what happens if it is denied. Get a straight answer on the PA process and the self-pay fallback price before your first visit, not after a denial letter arrives.
Whether canceling the broader membership also cancels your GLP-1 access. Since weight management sits inside a larger telehealth account, confirm what happens to your prescription access if you cancel or downgrade the base membership later.
Useful Extras Worth Owning
These cover the realistic range of what actually helps, from the one item worth buying first to the small extra that makes the rest of the list easier to use.
LifeMD’s intake and periodic visits typically ask for a recent blood pressure reading; having your own cuff means you are not relying on a number from months ago.
View on Amazon →A concrete, low-effort way to see actual portions between visits, useful regardless of which platform is managing the prescription.
View on Amazon →Keeps injection days and any other medications on one visible weekly schedule, which matters more once a membership adds its own visit reminders into the mix.
View on Amazon →LifeMD Self-Pay vs. Insurance-Covered Path
| Step | Self-Pay Path | Insurance Path |
|---|---|---|
| Eligibility check | Same FDA label BMI threshold | Same threshold, plus your plan’s own coverage criteria |
| Cost of the drug itself | about $499/mo Wegovy via NovoCare, about $349–499/mo Zepbound via LillyDirect | Copay varies by plan; a manufacturer savings card may still apply |
| Extra step required | None beyond intake and labs | Prior authorization submitted by your LifeMD prescriber |
| LifeMD membership fee | Applies regardless of the drug’s payment path | Applies regardless of the drug’s payment path |
| Typical timeline | 2–4 weeks to first shipment | 4–8 weeks including PA review, longer if appealed |
How to Decide Whether LifeMD Is Worth It
If you want one telehealth account that covers more than weight management, prefer a live clinician visit over pure asynchronous messaging, or are actively working an insurance-covered path and want a platform that will handle prior-authorization paperwork, LifeMD’s broader structure earns its place. If you only want the GLP-1 piece as cheaply and quickly as possible and have no interest in the rest of the membership, a narrower platform built around a single visit or a lighter subscription may fit better.
Whichever you choose, treat the first visit as a screening conversation rather than a purchase you have already committed to. Get the combined membership-plus-drug total in writing, confirm the brand-name path explicitly if that is what you are paying for, and if anything about the intake steers you toward a compounded product you did not ask for, treat that as a reason to look elsewhere rather than a shortcut worth taking.
Three Things This Review Doesn’t Cover
Product roundups answer which one. They do not answer the questions that come up regardless of which products you choose:
- Whether insurance could cover this at all — the prior-authorization and savings-card mechanics this review only summarizes.
- The step-by-step online prescription process — the eligibility check, labs, and timeline that apply no matter which platform you pick.
- What happens after the first dose ships — the side-effect timeline that has nothing to do with which platform wrote the prescription.